Log in

Relevant bibliographies by topics / Aspirine / Journal articles

To see the other types of publications on this topic, follow the link: Aspirine.

Journal articles on the topic 'Aspirine'

Author: Grafiati

Published: 4 June 2021

Last updated: 5 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Aspirine.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Devulder, B. "Immortelle aspirine…" La Revue de Médecine Interne 21 (March 2000): S5—S7. http://dx.doi.org/10.1016/s0248-8663(00)88719-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Atallah, Anthony, Edouard Lecarpentier, François Goffinet, Pascal Gaucherand, Muriel Doret-Dion, and Vassilis Tsatsaris. "Aspirine et prééclampsie." La Presse Médicale 48, no. 1 (2019): 34–45. http://dx.doi.org/10.1016/j.lpm.2018.11.022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Monsuez, J. J. "Maladie thromboembolique : aspirine." Archives des Maladies du Coeur et des Vaisseaux - Pratique 2012, no. 210 (2012): 38. http://dx.doi.org/10.1016/s1261-694x(12)70399-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Samama, M. M., and I. Elalamy. "Aspirine et hémostase." La Revue de Médecine Interne 21 (March 2000): S27—S34. http://dx.doi.org/10.1016/s0248-8663(00)88722-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Heynick, Frank. "Heroïne, Aspirine, Vioxx." TandartsPraktijk 26, no. 1 (2005): 22–26. http://dx.doi.org/10.1007/bf03072398.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Wautrecht, J. C. "Aspirine et prévention primaire." Journal des Maladies Vasculaires 37, no. 2 (2012): 72–73. http://dx.doi.org/10.1016/j.jmv.2011.12.022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Pradalier, A., and D. Vincent. "Aspirine: allergie ou intolérance." La Revue de Médecine Interne 21 (March 2000): S75—S82. http://dx.doi.org/10.1016/s0248-8663(00)88728-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Vergne, P., P. Bertin, and R. Trèves. "Aspirine, douleurs et inflammation." La Revue de Médecine Interne 21 (March 2000): S89—S96. http://dx.doi.org/10.1016/s0248-8663(00)88730-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Scherptong-Engbers, Marissa. "Aspirine voorkomt recidief trombose." Huisarts en wetenschap 55, no. 10 (2012): 432. http://dx.doi.org/10.1007/s12445-012-0214-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Stoffers, Jelle. "Aspirine bij claudicatio intermittens?" Huisarts en wetenschap 56, no. 9 (2013): 491. http://dx.doi.org/10.1007/s12445-013-0247-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Grancher, Adrien, Pierre Michel, Frédéric Di Fiore, and David Sefrioui. "Aspirine et cancer colorectal." Bulletin du Cancer 105, no. 2 (2018): 171–80. http://dx.doi.org/10.1016/j.bulcan.2017.09.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

van Gelder, T. "Aspirine bij type 2 diabetes." Medisch-Farmaceutische Mededelingen 47, no. 4 (2009): 56–57. http://dx.doi.org/10.1007/bf03079924.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Lazareth, I. "Aspirine et maladie thromboembolique veineuse." Journal des Maladies Vasculaires 38, no. 1 (2013): 1. http://dx.doi.org/10.1016/j.jmv.2012.12.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

D., Y. M. "MCV, CCR, la solution aspirine ?" Option/Bio 27, no. 547-548 (2016): 10. http://dx.doi.org/10.1016/s0992-5945(16)30198-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Benhamou, Y., and H. Lévesque. "Aspirine et maladie de Horton." Journal des Maladies Vasculaires 30, no. 1 (2005): 5–7. http://dx.doi.org/10.1016/s0398-0499(05)83791-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Crassard, I., P. Niclot, and M. G. Bousser. "Aspirine et accidents ischémiques cérébraux." La Revue de Médecine Interne 21 (March 2000): S41—S49. http://dx.doi.org/10.1016/s0248-8663(00)88724-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Hachulla, E., A. M. Piette, P. Y. Hatron, and O. Blétry. "Aspirine et syndrome des antiphospholipides." La Revue de Médecine Interne 21 (March 2000): S83—S88. http://dx.doi.org/10.1016/s0248-8663(00)88729-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Flinterman, Linda, Karin Hek, Joke Korevaar, and Liset van Dijk. "Maagzuurremmers en NSAID’s of aspirine." Huisarts en wetenschap 58, no. 9 (2015): 490. http://dx.doi.org/10.1007/s12445-015-0256-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Campos, Ana. "O Papel da Aspirina na Prevenção da Pré-Eclâmpsia: Estado da Arte." Acta Médica Portuguesa 28, no. 4 (2015): 517. http://dx.doi.org/10.20344/amp.6005.

Full text

Abstract:

<strong>Introduction:</strong> The role of acetyl salicylic acid (ASA or aspirin) in preeclampsia prevention and in other complications has been subject to studies and controversies for the last 30 years. The first research results concerning the role of placenta in preeclampsia have been published by the end of seventies and they showed an increase in the platelet activity and a prostaglandin synthesis disturbance, as a consequence of a deficient placentation. In the last twenty years of the XX century important studies were published on the aspirin<br />prophylactic role in preeclampsia risk reduction.<br /><strong>Material and Methods:</strong> To analyze published studies about Aspirin use for preeclampsia prevention and about the more adequate dosage to be administered, Medline was used for searching the most relevant prospective research papers on this subject in order to evaluate current evidence about the use of aspirin in this context. Relevant citations were extracted from Embase, PubMed and the Cochrane Central Register of Controlled Trials. We divided the studies in two groups; one with aspirine administration before 16 weeks and the other having a larger use, between the first and the third trimester.<br /><strong>Results and Discussion:</strong> The first group of studies, with a lesser number of cases but an earlier time of administration until 16 weeks, concluded that a positive role of aspirine was possible in reducing severity of preeclampsia; the second group with a larger number of cases but less restricted conditions and timing of administration, had controversial results, with reduced positive actions of the drug. Meta-analysis of these published studies concluded that favorable results were associated to stricter criteria and ideal timing for starting<br />the drug.<br /><strong>Conclusion:</strong> As we do not have other pharmacologic alternatives, low dosage of Aspirin between 80-150 mg a day in the first trimester and until 16 weeks, at evening time, is a possible choice in cases of risk, and is still contributing for an early preeclampsia risk reduction.

APA, Harvard, Vancouver, ISO, and other styles

20

M., J. M. "Aspirine, AINS et risque de CCR." Revue Francophone des Laboratoires 2015, no. 476 (2015): 15. http://dx.doi.org/10.1016/s1773-035x(15)30272-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Dalmat, Yann-Mickael. "Aspirine traitement préventif du carcinome hépatocellulaire ?" Option/Bio 31, no. 617-618 (2020): 9. http://dx.doi.org/10.1016/s0992-5945(20)30137-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Monsuez, J. J. "Aspirine et récidive de thrombose veineuse." Archives des Maladies du Coeur et des Vaisseaux - Pratique 2013, no. 214 (2013): 38–39. http://dx.doi.org/10.1016/s1261-694x(13)70459-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Meillard, Olivier. "Aspirine : quelle est la meilleure dose ?" Actualités Pharmaceutiques 48, no. 482 (2009): 7. http://dx.doi.org/10.1016/s0515-3700(09)70030-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Karila-Cohen, D., and P. Gabriel Steg. "Aspirine et prévention du risque cardiovasculaire." La Revue de Médecine Interne 21 (March 2000): S35—S40. http://dx.doi.org/10.1016/s0248-8663(00)88723-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Beaufils, M. "Aspirine et prévention de la prééclampsie." La Revue de Médecine Interne 21 (March 2000): S68—S74. http://dx.doi.org/10.1016/s0248-8663(00)88727-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Berenbaum, F. "AINS et aspirine : Amis ou ennemis ?" Revue du Rhumatisme 70, no. 1 (2003): 7–8. http://dx.doi.org/10.1016/s1169-8330(02)00023-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

van Maanen, Hans. "De vele vaders van aspirine (1)." Huisarts en wetenschap 58, no. 1 (2015): 11. http://dx.doi.org/10.1007/s12445-015-0009-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

van Maanen, Hans. "De vele vaders van aspirine (2)." Huisarts en wetenschap 58, no. 2 (2015): 77. http://dx.doi.org/10.1007/s12445-015-0043-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Toll, P. J. M. M. "Gastro-intestinale veiligheid van nitro-aspirine." Medisch-Farmaceutische Mededelingen 42, no. 6 (2004): 156. http://dx.doi.org/10.1007/bf03058397.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Benamouzig, Robert, and Stanislas Chaussade. "Aspirine et foyers de cryptes aberrantes coliques." Gastroentérologie Clinique et Biologique 28, no. 2 (2004): 204. http://dx.doi.org/10.1016/s0399-8320(04)94884-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Lechat, P. "Antivitamines K, aspirine: des traitements toujours d'actualité." La Revue de Médecine Interne 18 (May 1997): s91—s92. http://dx.doi.org/10.1016/s0248-8663(97)80300-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Belhomme, N., C. Doudnikoff, E. Polard, B. Henriot, H. Isly, and P. Jego. "Aspirine : indications et utilisation durant la grossesse." La Revue de Médecine Interne 38, no. 12 (2017): 825–32. http://dx.doi.org/10.1016/j.revmed.2017.10.419.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

. "988 Promotie: Aspirine Laat Symptomen Schizofrenie Afnemen." Zorg en Financiering 7, no. 7 (2008): 135. http://dx.doi.org/10.1007/bf03097224.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Stalenhoef, Ans. "‘Aspirine moet je ’s avonds laten slikken!’." Huisarts en wetenschap 58, no. 6 (2015): 332–33. http://dx.doi.org/10.1007/s12445-015-0171-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Aboyans, V. "Aspirine et prévention cardiovasculaire : certitudes et incertitudes." JMV-Journal de Médecine Vasculaire 44, no. 2 (2019): 101. http://dx.doi.org/10.1016/j.jdmv.2018.12.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Périchon, B., and R. Krishnamoorthy. "Aspirine et facteurs de susceptibilité à l'asthme." Archives de Pédiatrie 2 (January 1995): S102—S103. http://dx.doi.org/10.1016/0929-693x(96)89858-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

De Schryver, E. L. L. M., J. W. Gorter, A. Algra, and J. van Gijn. "Prévention des complications vasculaires après ischémie cérébrale d'origine artérielle. Étude ESPRIT: anticoagulation modérée, association aspirine-dipyridamole ou aspirine seule ?" La Revue de Médecine Interne 20, no. 5 (1999): 397–99. http://dx.doi.org/10.1016/s0248-8663(99)83089-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Arrondeau, J., and F. Bost. "Metformine et aspirine : de « nouveaux » traitements du cancer ?" Oncologie 15, no. 9 (2013): 480–89. http://dx.doi.org/10.1007/s10269-013-2319-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Lagarce, Laurence, Françoise Boyer, Corinne Bruhat, Bertrand Diquet, and Pascale Lainé-Cessac. "Thrombopénie sous aspirine, un effet indésirable souvent méconnu." Therapies 59, no. 6 (2004): 649–51. http://dx.doi.org/10.2515/therapie:2004112.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Andreelli, F. "Aspirine, anti-oxydants et diabète de type 2." Médecine des Maladies Métaboliques 2, no. 6 (2008): 633. http://dx.doi.org/10.1016/s1957-2557(08)74936-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Dassonvilie, L., Y. Ollivier, A. Zoulim, et al. "Péricardites aiguës récidivantes. Intérêt de l'association colchicine-aspirine." La Revue de Médecine Interne 23 (May 2002): 112s. http://dx.doi.org/10.1016/s0248-8663(02)80231-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Van de Streek, Jenneke. "HLA-klasse I voorspelt effect aspirine bij darmkanker." Mednet 6, no. 11-12 (2013): 19. http://dx.doi.org/10.1007/s12462-013-0313-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Waard, Margreet Wieringa-de. "Miskramen niet te voorkomen door aspirine of nadroparine." Huisarts en wetenschap 54, no. 3 (2011): 170. http://dx.doi.org/10.1007/s12445-011-0075-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Schmidt, C. "Étude contrôlée et randomisée de l’association aspirine-dipyridamole versus aspirine seule en prévention secondaire après ischémie cérébrale d’origine artérielle (ESPRIT)." Journal des Maladies Vasculaires 31, no. 5 (2006): 294–95. http://dx.doi.org/10.1016/s0398-0499(06)77455-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Boukais, H. "Antiagrégants plaquettaires et extractions dentaires : étude comparative des complications hémorragiques dans deux groupes de patients : aspirine versus aspirine+clopidogrel (Plavix®)." La Revue de Médecine Interne 31 (December 2010): S385. http://dx.doi.org/10.1016/j.revmed.2010.10.102.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Iung, Bernard. "Aspirine et AVK chez les porteurs de prothèse valvulaire." Archives des Maladies du Coeur et des Vaisseaux - Pratique 2004, no. 125 (2004): 9. http://dx.doi.org/10.1016/s1261-694x(04)73337-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Harskamp, Ralph, and Geert-Jan Geersing. "Duale plaatjesremming of alleen aspirine voor secundaire cardiovasculaire preventie." Huisarts en wetenschap 61, no. 7 (2018): 66. http://dx.doi.org/10.1007/s12445-018-0193-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Cajfinger, F. "Aspirine et cancer : de la théorie à la pratique." JMV-Journal de Médecine Vasculaire 44, no. 2 (2019): 101. http://dx.doi.org/10.1016/j.jdmv.2018.12.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

de Vries, H. R. "Ibuprofen en aspirine: de stand is nog steeds onbeslist." Medisch-Farmaceutische Mededelingen 42, no. 6 (2004): 154. http://dx.doi.org/10.1007/bf03058395.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Schmidt, C. "Association clopidogrel-aspirine vs aspirine-placebo à la phase aiguë de l’infarctus du myocarde: essai randomisé et contrôlé chez 45 852 patients." Journal des Maladies Vasculaires 31, no. 2 (2006): 108–9. http://dx.doi.org/10.1016/s0398-0499(06)77445-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!